Advertisement

  • Treating Fear of Recurrence

    Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.

    by Jon Kelvey

  • FORWARD LOOK

    A New Use for Patient Data

    Gregory Daniel on real-world evidence for cancer drug approvals.

    by Sue Rochman

  • What to Do About Lymphedema?

    In a randomized study, weight loss and home-based exercise did not improve lymphedema symptoms in breast cancer survivors.

    by Anna Azvolinsky

  • The Right Dose

    Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.

    by Kate Yandell

  • Q&A

    Breaking the Ice

    Social activist and breast cancer survivor Letty Cottin Pogrebin shares tips on supporting friends and family members through cancer diagnosis and treatment.

    by Marci A. Landsmann

  • New Rule Would Require Breast Density Disclosure

    A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.

    by Carly Weeks

  • FORWARD LOOK

    Looking for Brain Metastases

    Studies aim to identify when screening is beneficial.

    by Sue Rochman

  • First Immunotherapy Approved for Breast Cancer

    Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

    by Anna Azvolinsky

  • Considering the Term “Cancer Survivor”

    A study investigates how people who have been diagnosed with cancer feel about being called survivors.

    by Jen Tota McGivney

  • Treating Breast Cancer in Men

    Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.

    by Marilyn Fenichel

Advertisement
Advertisement

From the AACR

  • Targeting KRAS

    After decades of failed efforts to target the elusive KRAS, encouraging data suggest KRAS could finally be dethroned from the “undruggable” category.

  • New FDA Approval

    The U.S. Food and Drug Administration has approved an ovarian cancer treatment based on new biomarker.

  • Advances in Lung Cancer Research and Treatment

    Lung cancer—one of the most commonly diagnosed cancers in the United States—is an area of intense research and clinical development.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR